We are live on ! Find out more
PFCS

Pale Fire Capital SE Portfolio holdings

AUM $1.14B
1-Year Est. Return 42.87%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+42.87%
3 Year Est. Return
+176.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$640M
AUM Growth
-$355M
Cap. Flow
-$361M
Cap. Flow %
-56.35%
Top 10 Hldgs %
81.69%
Holding
93
New
19
Increased
28
Reduced
15
Closed
19

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$23.9M
2
ANGI icon
Angi Inc
ANGI
+$10.1M
3
NOMD icon
Nomad Foods
NOMD
+$9.76M
4
CGAU
Centerra Gold
CGAU
+$9.1M
5
TDOC icon
Teladoc Health
TDOC
+$7.67M

Top Sells

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$204M
2
BP icon
BP
BP
+$116M
3
INSW icon
International Seaways
INSW
+$21.1M
4
TNK icon
Teekay Tankers
TNK
+$16.2M
5
TALO icon
Talos Energy
TALO
+$13.3M

Sector Composition

Rank Sector Weight
1 Energy 47.79%
2 Communication Services 20.12%
3 Consumer Staples 17.15%
4 Consumer Discretionary 5.33%
5 Industrials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRX
51
DELISTED
Chimerix, Inc.
CMRX
$203K 0.03%
211,214
+112,318
+114% +$109K
FLWS icon
52
1-800-Flowers.com
FLWS
$269M
$189K 0.03%
17,572
-32,693
-65% -$280K
CYT
53
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$175K 0.03%
57,597
– –
TSVT
54
DELISTED
2seventy bio
TSVT
$174K 0.03%
40,688
+16,400
+68% +$50.4K
CRBU icon
55
Caribou Biosciences
CRBU
$149M
$162K 0.03%
+28,200
New +$139K
BDTX icon
56
Black Diamond Therapeutics
BDTX
$99.7M
$144K 0.02%
+51,100
New +$120K
CMPS
57
CALL
Compass Pathways
CMPS
$1.52B
$140K 0.02%
+16,000
New +$104K
IOVA icon
58
Iovance Biotherapeutics
IOVA
$1.93B
$138K 0.02%
17,024
+1,924
+13% +$10.1K
TCRX icon
59
TScan Therapeutics
TCRX
$47.3M
$126K 0.02%
21,573
+4,998
+30% +$22.9K
BCAB icon
60
BioAtla
BCAB
$5.41M
$119K 0.02%
968
+650
+204% +$56.3K
CWK icon
61
Cushman & Wakefield Ltd
CWK
$3.18B
$108K 0.02%
+10,000
New +$83.3K
IGMS
62
DELISTED
IGM Biosciences
IGMS
$96.4K 0.02%
11,601
-1,000
-8% -$5.81K
VNDA icon
63
CALL
Vanda Pharmaceuticals
VNDA
$315M
$93.3K 0.01%
+22,100
New +$89.2K
HUMA icon
64
CALL
Humacyte
HUMA
$186M
$91.2K 0.01%
+32,100
New +$82.4K
TNYA icon
65
Tenaya Therapeutics
TNYA
$158M
$91K 0.01%
28,100
– –
MNKD icon
66
CALL
MannKind Corp
MNKD
$1.17B
$91K 0.01%
25,000
+2,200
+10% +$8.4K
CDMO
67
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$71.5K 0.01%
+11,000
New +$70.9K
KZR
68
DELISTED
Kezar Life Sciences
KZR
$65.2K 0.01%
6,885
– –
MRSN
69
DELISTED
Mersana Therapeutics
MRSN
$58.9K 0.01%
1,016
– –
LRMR icon
70
Larimar Therapeutics
LRMR
$413M
$54.8K 0.01%
12,040
– –
CDTX
71
DELISTED
Cidara Therapeutics
CDTX
$52.8K 0.01%
3,327
+609
+22% +$9.78K
OKUR
72
OnKure Therapeutics
OKUR
$162M
$48.2K 0.01%
3,010
+1,525
+103% +$95K
DSGN icon
73
Design Therapeutics
DSGN
$797M
$27.8K ﹤0.01%
+10,500
New +$24.1K
NGM
74
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$26.4K ﹤0.01%
30,700
-3,100
-9% -$2.72K
ACRS icon
75
Aclaris Therapeutics
ACRS
$772M
– –
-13,000
Closed -$89K
1 2
3
4

Similar funds

WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
SAM
SP Asset Management Cupertino, California $1.13B AUM 12.57% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
BBP
Banco BTG Pactual Rio De Janeiro, Brazil $1.14B AUM 41.39% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return

Pale Fire Capital SE's Q4 2023 Portfolio in Review

As of Q4 2023, Pale Fire Capital SE held 93 positions worth $640M, down 36% from $995M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Pale Fire Capital SE withdrew a net $361M in Q4 2023, closing 19 positions and reducing 15 holdings. Its most notable exit was Talos Energy, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Energy at 48% of assets, down from 70% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, Pale Fire Capital SE opened a new position in Teladoc Health worth $8.96M.

  • Pale Fire Capital SE's largest Q4 2023 buy was Teladoc Health: 415,797 shares worth $8.96M.
  • Pale Fire Capital SE added most to Alibaba in Q4 2023, an estimated $23.9M increase.
  • Pale Fire Capital SE's biggest Q4 2023 reduction was Shell, cutting an estimated $204M.
  • Pale Fire Capital SE fully exited Talos Energy in Q4 2023, selling an estimated $13.3M.
  • Pale Fire Capital SE's ten largest holdings make up 82% of its $640M portfolio in Q4 2023.
  • Pale Fire Capital SE opened 19 new positions and closed 19 in Q4 2023.
  • Pale Fire Capital SE's portfolio value fell 36% quarter-over-quarter to $640M.

Based on Pale Fire Capital SE's 13F filing for Q4 2023, filed 13 Feb 2024.